logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Life Biosciences Receives Translational Research Funding From Alzheimer'S Drug Discovery Foundation

Sep 28, 2021•about 4 years ago
Boston

Description

Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced translational research funding from the Alzheimer's Drug Discovery Foundation (ADDF) to support the development of chaperone-mediated autophagy (CMA) activators for the treatment of Alzheimer's disease and other neurodegenerative diseases.

Company Information

Company

Life Biosciences

Location

Boston, Massachusetts, United States

About

Life Biosciences is a private biotechnology company dedicated to discovering and developing novel therapies to improve the lives of people as they age. The company is focusing on three platforms targeting key mechanisms underlying aging biology: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Therapies developed within each platform have the potential to prevent, treat, and/or reverse multiple aging-related diseases. For more information, please visit www.lifebiosciences.com.